Divided Time For FDA, Danco Requested Ahead Of High Court Oral Arguments
WASHINGTON, D.C. — The U.S. solicitor general asked that the U.S. Supreme Court allow counsel for the U.S. Food and Drug Administration and Danco Laboratories LLC, the manufacturer of Mifeprex-brand mifepristone,...To view the full article, register now.
Already a subscriber? Click here to view full article